BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22531438)

  • 1. Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display.
    Votsmeier C; Plittersdorf H; Hesse O; Scheidig A; Strerath M; Gritzan U; Pellengahr K; Scholz P; Eicker A; Myszka D; Coco WM; Haupts U
    MAbs; 2012; 4(3):341-8. PubMed ID: 22531438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.
    Hoet RM; Cohen EH; Kent RB; Rookey K; Schoonbroodt S; Hogan S; Rem L; Frans N; Daukandt M; Pieters H; van Hegelsom R; Neer NC; Nastri HG; Rondon IJ; Leeds JA; Hufton SE; Huang L; Kashin I; Devlin M; Kuang G; Steukers M; Viswanathan M; Nixon AE; Sexton DJ; Hoogenboom HR; Ladner RC
    Nat Biotechnol; 2005 Mar; 23(3):344-8. PubMed ID: 15723048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
    Jackson JR; Sathe G; Rosenberg M; Sweet R
    J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Production and Batch Reformatting of Phage Antibody Libraries.
    Reader RH; Workman RG; Maddison BC; Gough KC
    Mol Biotechnol; 2019 Nov; 61(11):801-815. PubMed ID: 31468301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.
    Yang WP; Green K; Pinz-Sweeney S; Briones AT; Burton DR; Barbas CF
    J Mol Biol; 1995 Dec; 254(3):392-403. PubMed ID: 7490758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
    Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
    Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies.
    Hu D; Hu S; Wan W; Xu M; Du R; Zhao W; Gao X; Liu J; Liu H; Hong J
    PLoS One; 2015; 10(6):e0129125. PubMed ID: 26046845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.
    Koenig P; Lee CV; Sanowar S; Wu P; Stinson J; Harris SF; Fuh G
    J Biol Chem; 2015 Sep; 290(36):21773-86. PubMed ID: 26088137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A general approach to antibody thermostabilization.
    McConnell AD; Zhang X; Macomber JL; Chau B; Sheffer JC; Rahmanian S; Hare E; Spasojevic V; Horlick RA; King DJ; Bowers PM
    MAbs; 2014; 6(5):1274-82. PubMed ID: 25517312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in affinity and HIV-1 neutralization by somatic mutation in the heavy chain first complementarity-determining region of antibodies triggered by HIV-1 infection.
    Torán JL; Sánchez-Pulido L; Kremer L; del Real G; Valencia A; Martínez-A C
    Eur J Immunol; 2001 Jan; 31(1):128-37. PubMed ID: 11169446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust in vitro affinity maturation strategy based on interface-focused high-throughput mutational scanning.
    Fujino Y; Fujita R; Wada K; Fujishige K; Kanamori T; Hunt L; Shimizu Y; Ueda T
    Biochem Biophys Res Commun; 2012 Nov; 428(3):395-400. PubMed ID: 23103372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved binding activity of antibodies against major histocompatibility complex class I chain-related gene A by phage display technology for cancer-targeted therapy.
    Phumyen A; Jumnainsong A; Leelayuwat C
    J Biomed Biotechnol; 2012; 2012():597647. PubMed ID: 23226940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage display aided improvement of a unique prostate-specific antigen (PSA) antibody unreactive with Lys(145)-Lys(146) internally cleaved forms.
    Liton MF; Peltola MT; Vehniäinen M; Kuusela E; Pettersson T; Lamminmäki U; Pettersson K; Brockmann EC
    J Immunol Methods; 2015 Jul; 422():72-9. PubMed ID: 25889751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of high affinity p-azophenyarsonate Fabs from heavy-chain CDR2 insertion libraries.
    Parhami-Seren B; Viswanathan M; Margolies MN
    J Immunol Methods; 2002 Jan; 259(1-2):43-53. PubMed ID: 11730840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation.
    Li B; Fouts AE; Stengel K; Luan P; Dillon M; Liang WC; Feierbach B; Kelley RF; Hötzel I
    MAbs; 2014; 6(2):437-45. PubMed ID: 24492299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a large synthetic human Fab antibody library on yeast cell surface by optimized yeast mating.
    Baek DS; Kim YS
    J Microbiol Biotechnol; 2014 Mar; 24(3):408-20. PubMed ID: 24394194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.